IT HAS BEEN SHOWN that in (A x CBA/ T6)F1 mice the presence of an F1 tumour inhibits the graft-versus-host reaction (GvHR) induced by injection of A strain spleen cells (Whitmarsh-Everiss & Symes, 1981 ). This conclusion was based on the finding that the presence of a tumour significantly reduced the increase in spleen weight produced by injection of parentline cells. It seemed relevant to extend these findings by studying the effect of tumour resection on susceptibility to GvHR. Also, Howard (1961) found that macrophage reactivity is increased in mice undergoing GvHR, and activated macrophages show increased sensitivity to lipopolysaccharide (LPS) as judged by a rise in plasma enzyme levels after endotoxin administration (Howard, 1969; Shands & Senterfitt, 1972; Ferluga & Allison, 1978) . It thus seemed possible to use changes in enzyme levels following endotoxin administration to confirm our hypothesis that the presence of a tumour protects against GvHR. Macrophage activation in GvHR is maximal in the liver (Howard, 1961) Tumour-cell suspensions were prepared by the method of Milas et al. (1974) .
The F1 mice used as recipients of tumour transplants and A-strain cells were females aged 2-3 months.
The A mice which acted as spleen-cell donors were females aged 1-2 months. They had been immunized by transplantation of the appropriate F1 tumour, 9 days beforehand.
The spleen ratio of each mouse was defined as wt of spleen (mg)/wt of mouse (g). The spleen index was obtained by dividing the spleen ratio of a particular mouse by the mean spleen ratio of the mice in the appropriate control group; e.g. spleen ratio of individual mouse undergoing a GvHR from which the tumour was resected divided by mean spleen ratio of mice in group from which tumour was resected only (no spleen cells injected). For an example of the calculations involved see Whitmarsh-Everiss & Symes (1981) .
The total data for a given parameter was pooled and subjected to a one-way analysis of variance. The significance of individual differences was then found by using a common variance (based on the residual sum of squares) to calculate t.
In Expt 1 (Table I) injection of A spleen cells into non-tumour-bearing mice produced a GvHR (mean spleen index 2.33), which was significantly reduced in the presence of a tumour transplant (mean index 1 -40). At the same time injection of A spleen cells into tumourbearing F1 mice reduced the weight of the tumour as recorded 10 days later (median value 0-85 g), in comparison with that in tumour-bearing mice not receiving parent-line cells (median value 1 * 44 g; P < 0 05 Rank-sum test).
In Expt 2 injection of parent-line cells did not significantly reduce tumour weights on Day 8 thereafter. In parallel with this observation, the presence of a tumour did not reduce the level ofGvHR following injection of parent-line cells (Tahle I).
In Expt 3, as in Expt 1, the presence of a tumour significantly reduced the magnitude of the GvHR, and tumour resection abolished this effect (Table I) . Injection of parent-line cells also led to a significant reduction in tumour weight (median values 0-87 g for mice receiving cells vs 2-10 g for control tumours, P= 0.025).
OCT is found only in the mitochondria of hepatocytes (Vassef, 1978) . This enzyme is liberated by damage to the appropriate cells, as reflected by a rise in its plasma level. The plasma levels of OCT were similar in all groups of mice not receiving LPS in Expts 1 and 2. This is evidence for a 2-stage process, in which GvHR activates macrophages from which endotoxin then triggers lysosomal-enzyme release (Ferluga & Allison, 1978) writh consequent damage to the surrounding liver tissue. After injection of LPS, the mice undergoing a GvHR due to injection of parentline cells, showed a significantly raised OCT level in comparison with untreated mice receiving no LPS (Expt 4, Table II ). This rise in OCT level was abolished when the GvHR occurred in the presence of a tumour, but the OCT level was again significantly raised if the tumour was resected 1 day before induction of GvHR.
On repeating this experiment (Expt 5, Table II) in further groups of mice, induction of GvHR was again associated with a significant rise in OCT levels. This was abrogated by the presence of a tumour, but enzyme levels were again increased if the tumour was resected.
A difference between Expts 4 and 5 was the effect of LPS injection on OCT levels in normal mice. The OCT level was raised in Expt 4 (Table II) which accords with the finding of Bradfield et al. (1980) but not in Expt 5 (Table II) .
The increase in OCT levels in nontumour-bearing mice undergoing GvH R indicated the sensitivityN of activated liver macrophages to LPS challenge (Table   11) .
It was not possible to measure spleen weights and plasma-enzyme levels (after LPS injection) in the same mice, as administration of endotoxin caused a dramatic reduction in spleen weight, possibly due to splenic contraction associated with shock. Symes (1981) showed that an A-strain tumour growing in (A x CBA) F1 mice, did not protect against GvHR by A spleen cells. In this genetic combination, the A spleen cells, being isogenic with the tumour, could not react with it, and accordingly the tumour size was not reduced in animals undergoing GvHR. An alternative or additional mechanism by which a tumour acts is suggested by the work of Cheung et al. (1979) who found that tumour-derived products can inhibit induction of macrophage tumoricidal activity by LPS. Other studies have also shown that tumours produce a lowmol-wt factor capable of inhibiting the spreading adhesion and migration of macrophages (Cantarow et al., 1978; Fauve & Hevin, 1977 ) macrophage chemotaxis in vitro (Snyderman & Pike, 1976; Nelson & Nelson, 1978) macrophagemediated resistance to Listeria infection (North et al., 1976) and the early phase of delayed-type hypersensitivity reaction to SRBC in vivo (Nelson & Nelson, 1978) .
Thus in the present study, tumour products may inhibit the release by LPS of enzymes from macrophages activated by GvHR.
The idea that a tumour may deflect the immune response of foreign cells to itself with consequent protection of the host against GvHR, may stimulate attempts to treat neoplasms by adoptive transfer of immunologically competent cells.
